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Telomerase is an enzyme that utilizes an internal RNA molecule as a template for the extension of chromosomal DNA
ends. The catalytic core of telomerase consists of the RNA subunit and a protein reverse transcriptase subunit, known as
telomerase reverse transcriptase (TERT). It has previously been shown that both yeast and human telomerase can form
dimers or multimers in which one RNA in the complex can influence the activity of another. To test the proposal that
dimerization might be essential for telomerase activity, we sought to determine whether Tetrahymena thermophila
telomerase is active as a dimer or a monomer. Recombinant Tetrahymena telomerase eluted from a gel filtration column
at the size of a monomeric complex (one RNA plus one TERT), and those fractions showed processive telomerase activity.
We were unable to detect dimerization of Tetrahymena telomerase by coprecipitation experiments, by using tags on either
the TERT protein or telomerase RNA. Therefore, a majority, if not all, of the recombinant Tetrahymena telomerase in our
reconstitution system is present as a monomeric complex. We were also unable to detect dimerization of native telomerase
from mating and vegetative Tetrahymena cell extracts. These results demonstrate that Tetrahymena telomerase does not
need to dimerize to be active and processive.
INTRODUCTION
Telomeres form a protective cap on chromosome ends and
are usually composed of short G-rich DNA repeats com-
plexed with proteins (reviewed in McEachern et al., 2000).
The telomeres of unicellular eukaryotes and of the germ cells
of multicellular organisms are maintained by the enzyme
telomerase, which was first identified in the ciliated proto-
zoan Tetrahymena thermophila (Greider and Blackburn, 1985).
Telomerase activity has been detected in many human can-
cer cells and seems to be necessary for their continued
growth (Shay and Bacchetti, 1997; Hahn et al., 1999; Zhang et
al., 1999).
The catalytic core of telomerase consists of the RNA sub-
unit (Greider and Blackburn, 1987) and a protein catalytic
subunit, known as telomerase reverse transcriptase (TERT)
(Lingner et al., 1997). Although a complex consisting of
TERT and telomerase RNA is sufficient to reconstitute te-
lomerase activity (Weinrich et al., 1997; Beattie et al., 1998;
Masutomi et al., 2000; Wenz et al., 2001), other components of
the telomerase holoenzyme have been identified in various
organisms (reviewed in Bryan and Cech, 1999).
The telomerase complex from nuclear extracts of immortal
human cells fractionates at 1000 kDa (Schnapp et al., 1998),
although this size is reduced to 550–600 kDa upon affinity
purification of telomerase, probably reflecting loss of loosely
associated subunits (Schnapp et al., 1998; Wenz et al., 2001).
The size of the smaller complex is consistent with being a
dimer of two TERT molecules (127 kDa each) and two
telomerase RNA molecules (150 kDa each), although this
would not leave any room for other telomerase subunits
such as hEst1 (160 kDa) (Reichenbach et al., 2003; Snow et al.,
2003). By using an affinity purification technique to measure
the number of telomerase RNA molecules in the complex, it
was confirmed that baculovirus-expressed recombinant hu-
man telomerase does in fact exist as a dimer (Wenz et al.,
2001). A number of other studies have confirmed that re-
combinant human telomerase is capable of forming both
physical and functional multimers (Armbruster et al., 2001;
Beattie et al., 2001; Arai et al., 2002; Moriarty et al., 2002).
Dimerization of human telomerase may be mediated by a
“trans-pseudoknot” between two RNA molecules, similar to
intermolecular interactions between RNA templates of ret-
roviral reverse transcriptases (Ly et al., 2003).
The situation for yeast telomerase is more complex. Pres-
cott and Blackburn (1997) provided convincing evidence for
more than one active site in yeast telomerase complexes
assembled in vivo). On the other hand, Livengood et al.
(2002) found nonoverlapping deletions in the telomerase
RNA that led to loss of coimmunoprecipitation with Est1p (a
yeast telomerase component), or with Est2p (yeast TERT),
but not both; these findings are difficult to reconcile with a
dimer or multimer, because their yeast strain also contained
intact telomerase RNA, which in a dimer (multimer) model
would complex with the deleted RNA and lead to substan-
tial coimmunoprecipitation. Similarly, an Est2p mutant pro-
tein failed to coprecipitate Est1p and Est3p even in the
presence of wild-type Est2p (Friedman et al., 2003). Thus,
these authors suggested that yeast telomerase is not an
obligate multimer in the steady state. This can be reconciled
with the identification of multimeric complexes if such com-
plexes occur during specific stages of the cell cycle or certain
subcellular locations, such as the telomere.
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Although the role of telomerase dimerization remains
unknown, the fact that one molecule in the subunit can
positively or negatively influence the level of activity of the
other molecule (Prescott and Blackburn, 1997; Beattie et al.,
2001; Wenz et al., 2001; Ly et al., 2003) implies a biological
function for the interaction. Several models for the role of
telomerase dimerization have been proposed, including the
coordinate replication of two telomeres simultaneously, or
the switching of primer between two templates to accom-
plish processive elongation (Wenz et al., 2001). Knowledge
of the multimerization state of telomerase is therefore fun-
damental to knowledge of the mechanism of the enzyme.
Telomerase isolated from the ciliate Euplotes aediculatus
can occur as either a monomer or a dimer (Lingner and
Cech, 1996; Aigner et al., 2003), whereas Euplotes crassus
telomerase undergoes multimerization (Wang et al., 2002).
Gel filtration analysis of telomerase from Tetrahymena ther-
mophila showed a complex of 500 kDa in both vegetative
and mated cells (Wang and Blackburn, 1997), which is in-
conclusive in regards to the multimerization state of telom-
erase because the protein composition of the complexes was
not known. We therefore sought to determine the multim-
erization state of active recombinant Tetrahymena telomerase
by using a variety of techniques. We found no evidence for
dimerization of Tetrahymena telomerase, suggesting that




The construction of a synthetic Tt_TERT gene has been described previously
(Bryan et al., 2000). This gene was inserted into the vector pET-28a (Novagen,
Madison, WI) to give the construct pET-28a-TERT, encoding Tetrahymena
TERT with N-terminal T7 and 6  His tags (Bryan et al., 2000). This plasmid
was modified to give pFLAG-TERT by insertion of oligonucleotides encoding
a FLAG tag in place of the N-terminal T7 and 6  His tags.
A plasmid containing the Tetrahymena telomerase RNA gene, a promoter
for T7 RNA polymerase and a hammerhead ribozyme self-cleavage domain to
process the 5 end of the RNA has been described and called pTET-telo (Zaug
and Cech, 1995). Polymerase chain reaction (PCR) mutagenesis was used to
make a mutant version of pTET-telo, with a C-to-U mutation at position 48 of
the telomerase RNA (pTET-telo-48U); this plasmid was a gift from Art Zaug.
A plasmid containing tandem Tetrahymena telomerase RNA genes separated
by a 12-nt linker was constructed by PCR amplification of the gene from
pTET-telo-48U (with primers tb115 [5-CGCGGATCCATACCCGCTTAAT-
TCATTCAG] and tb116 [5-AAAACTGCAGGCTCTTCCAAAATAAGA-
CATC]) followed by its insertion into the BamHI and PstI sites of pTET-telo,
downstream of the existing telomerase RNA gene. This construct (pTET-telo-
48U-3) contains a C48U mutation in the 3 half of the double RNA. A second
plasmid (pTET-telo-48U-5) containing a 48U mutation in the 5 half of the
double RNA was constructed in an analogous manner.
A plasmid (phTRhh) designed for in vitro transcription of human telom-
erase RNA (hTR) was a gift from Jamie Sperger (University of Colorado,
Boulder, CO). The hTR gene was amplified from a previously described
pGEM-based construct (Bryan et al., 1997) and inserted into pUC19 down-
stream of a promoter for T7 RNA polymerase and a hammerhead ribozyme
self-cleavage domain to process the 5 end of the RNA.
A version of pTET-telo containing a two-nucleotide nontemplate mutation
in the Tetrahymena telomerase RNA (AU65–66CC) was a gift from Jamie
Sperger. Versions of this plasmid and the wild-type pTET-telo lacking the
hammerhead sequence and the first 20 nt of the telomerase RNA were
constructed [called pTET-telo21-159(65/66) and pTET-telo21-159 respective-
ly]. They were constructed by PCR from the respective template plasmid with
primers tb111 (5-CAGTGAATTCTAATACGACTCACTATAGATCTGTAA-
TAGAACTGTCA) and ttmut6 (5-GCAGTGAGCGCAACGCAATTAATG),
digestion of the PCR products with EcoRI and BamHI and ligation into
EcoRI/BamHI digested pUC19.
Translation and Reconstitution of
Tetrahymena Telomerase
Tetrahymena telomerase RNA was transcribed in vitro from the plasmids
pTET-telo, pTET-telo-48U-5 or pTET-telo-48U-3 as described previously
(Bryan et al., 2000), except that the latter two plasmids were linearized with
SapI before transcription rather than EarI. All RNAs were gel-purified before
inclusion in in vitro translation reactions using pET-28a-TERT to translate
Tetrahymena TERT protein. The translations were carried out using the TnT;
rabbit reticulocyte lysate system (Promega, Madison, WI), as per the manu-
facturer’s directions and as described previously (Bryan et al., 2000). The
reactions included 20 ng/l plasmid DNA, 0.8 Ci/l [35S]methionine, and
20 nM (wild-type Tetrahymena) or 200 nM (Tetrahymena double RNA) telom-
erase RNA. The amount of TERT protein produced was estimated by elec-
trophoresis of a portion of the reaction on an SDS-PAGE gel and scintillation
counting of the excised protein band in comparison with [35S]methionine
standards (Donato et al., 1988). We estimated yields of 20 nM of full-length
TERT. Although the concentration of telomerase RNA added to the reaction
was equal to or greater than the amount of TERT translated, a large propor-
tion of the TERT was apparently not bound to RNA (Figure 1B). This is
presumably due to degradation of a portion of the telomerase RNA in the
translation reaction.
Gel Filtration
Reticulocyte lysate translation reactions (600 l) were either loaded on a
Sephacryl gel filtration column directly or treated in one of three ways before
loading: 1) buffer exchanged on a Microcon 100 filter unit (Millipore, Bedford,
MA) by three rounds of addition of 200 l of TMG-150 buffer (10 mM Tris
acetate, pH 8.0, 1 mM MgCl2, 10% glycerol, 150 mM potassium glutamate)
followed by centrifugation at 2500 g for 30 min at 4°C, resulting in recovery
of 800 l of sample; 2) buffer exchanged on a BioSpin P6 column (Bio-Rad,
Hercules, CA) by washing the column three times in TMG-150 followed by
centrifugation of the sample on the column at 1000  g for 4 min at 4°C; or 3)
filtration through a 0.2-m syringe filter. No differences were seen in subse-
quent elution patterns after these different treatments. Gel filtration was
performed on a Sephacryl S-300 16/60 column (120-ml bed volume) on a
fast-performance liquid chromatography machine (Amersham Biosciences,
Piscataway, NJ). The column was run at 0.25 ml/min in TMG-150 at 4°C and
2-ml fractions were collected. Fractions were flash frozen in liquid nitrogen
and stored at 80°C. Aliquots (20 l) were electrophoresed on 4–20% acryl-
amide SDS gels (Novex, San Diego, CA) that were analyzed with a Typhoon
PhosphorImager (Molecular Dynamics, Sunnyvale, CA) to detect 35S-labeled
TERT protein, and the bands quantitated with ImageQuant (Molecular Dy-
namics). Gel filtration standards (Amersham Biosciences) were run separately
on the same column under the same conditions, at concentrations of 6 mg/ml
(thyroglobulin, catalase, aldolase, and albumin) or 0.6 mg/ml (ferritin). The
parameter Kav was calculated for each standard using the following formula:
Kav(VeV0)/(Vt  V0)
where Ve is elution volume, V0 is void volume of column (40 ml) and Vt is
total volume of column (120 ml). A standard curve was obtained by plotting
Kav versus the logarithm of molecular mass and used for estimation of the
molecular mass of eluted samples.
Northern Blots
Gel filtration fractions (20 l) or input translation reaction (1 l) was added to
10 l of loading buffer (0.05% bromphenol blue, 0.05% xylene cyanol in
formamide), heated to 70°C for 10 min, loaded on a 1.5-mm-thick 4% poly-
acrylamide/8 M urea gel and electrophoresed at 35 W for 1 h. Radiolabeled
size markers were generated by transcription of Century Plus markers (Am-
bion, Austin, TX) in the presence of [-32P]CTP and 104 cpm were loaded on
the gel. The gel was transferred to Hybond-N nylon membrane (Amersham
Biosciences) on an electroblotter (Hoeffer, San Francisco, CA) in 0.5 Tris
borate-EDTA (45 mM Tris, 45 mM boric acid, 1 mM EDTA) at 0.5 A for 16 h.
The membrane was incubated in 10 ml of Church buffer (Church and Gilbert,
1985) at 55°C for 30 min, followed by addition of 5  106 cpm of 32P-labeled
oligonucleotide probe and incubation for 16 h at 55°C. The membrane was
then washed three times for 10 min at room temperature in 0.1 SSC/0.1%
SDS (15 mM sodium chloride, 1.5 mM sodium citrate, 0.1% SDS). The probe
used was Elu3b (5-TATCAGCACTAGATTTTTGGGGTTGAATG), against
Tetrahymena telomerase RNA. The membrane was analyzed with a Phospho-
rImager, and the bands were quantitated with ImageQuant.
Telomerase Activity Assays
Recombinant Tetrahymena telomerase activity was measured by incubating 24
l of gel filtration fractions or 1 l of column input in a 30-l reaction
including 1 telomerase buffer (50 mM Tris-Cl, pH 8.3, 1.25 mM MgCl2, 5
mM dithiothreitol [DTT]), 1 M primer [(GGGGTT)3], 100 M dTTP, and 10
M [-32P]dGTP at 80 Ci/mmol (0.1 l of nonradioactive dGTP at 2.7 mM
and 2.4 l of [-32P]dGTP at 10 mCi/ml, 800 Ci/mmol; PerkinElmer Life
Sciences, Boston, MA). The reaction was incubated at 30°C for 60 min and
then processed and electrophoresed on a 12% polyacrylamide/8M urea gel as
described previously (Bryan et al., 2000). A 100-mer DNA oligonucleotide was
radiolabeled with T4 polynucleotide kinase and [-32P]ATP and 5000 cpm
added to the reaction before phenol/chloroform extraction as a recovery
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control. Activity from Tetrahymena extracts was assayed in the same way with
two exceptions: 1) the final dGTP concentration in the reaction was 1.25 M
with a specific activity of 800 Ci/mmol, and 2) the internal DNA standard was
12 nt in length.
Tetrahymena Extract Preparations
T. thermophila strains B2086.1 and CU428.2 were gifts from Peter Bruns and
Donna Cassidy-Hanley (Cornell University, Ithaca, NY). Cells were grown
vegetatively or starved then mated, and harvested as described previously
(Bryan et al., 1998). S100 extracts were made from the cells as described
previously (Greider and Blackburn, 1987). The extracts were partially purified
on a 2 ml DEAE agarose (Bio-Rad) column. The column was equilibrated with
TMG (10 mM Tris acetate, pH 8.0, 1 mM MgCl2, 10% glycerol) before loading
5 ml of S100 extract, washed with 6 ml of TMG-200 (TMG plus 200 mM
potassium glutamate), and eluted with 12 ml of TMG-350 in 1-ml fractions.
Fractions containing active telomerase were pooled, flash frozen, and stored
at 80°C. Partially purified extract (430 l) was diluted to a final potassium
glutamate concentration of 150 mM with TMG before loading on a Sephacryl
S-300 column (see above), or dialyzed for 3 h into TMG at 4°C before use in
a telomerase activity assay (see below).
Immunoprecipitations
FLAG-tagged and T7-tagged TERT were translated in separate reticulocyte
lysate translation reactions (200-l total volume for each reaction), including
4 g of pFLAG-TERT or pET-28a-TERT, respectively, 200 nM telomerase
RNA, and other components as specified by the manufacturer (see above).
Two translations were carried out for each protein, one containing 160 Ci of
[35S]methionine and 4 l of “amino acid mixture minus methionine” (provid-
ed in the kit), and the other with no [35S]methionine, 4 l of amino acid
mixture minus methionine, and 4 l of “amino acid mixture minus leucine.”
After 60 min at 30°C, puromycin was added to a final concentration of 5
g/ml to stop translation. An aliquot (70 l) of FLAG-tagged TERT 35S was
mixed with an equal volume of T7-tagged TERT  35S, and incubated at 30°C
for 30–60 min. The opposite combination (T7-tagged  35S, FLAG-tagged 
35S) was also mixed and incubated. Each of these mixtures, as well as the
individual proteins, was immunoprecipitated with either T7-tag antibody-
agarose beads (Novagen) or anti-FLAG M2 affinity agarose beads (Sigma-
Aldrich, St. Louis, MO). Beads (50 l) were washed four times in 750 l of
wash buffer-50 (20 mM Tris acetate, pH 7.5, 10% glycerol, 1 mM EDTA, 5 mM
MgCl2, 0.1% Nonidet P-40, 1 mM DTT, 50 mM potassium glutamate), centri-
fuging at 1500 g for 2 min between washes. The beads were incubated twice
with 500 l of blocking buffer (wash buffer-50 plus 0.5 mg/ml lysozyme, 0.5
mg/ml bovine serum albumin, 0.05 mg/ml glycogen, 0.1 mg/ml yeast RNA)
for 15 min at 4°C with agitation. Reticulocyte lysate translation reaction or
mixture (50 l) was added to 50 l of blocking buffer and centrifuged at
16,000 g for 10 min at 4°C to remove any particulates. The supernatant from
that spin was added to 12.5 l of blocked beads and agitated at 4°C for 2 h.
The beads were washed four times in 185 l of wash buffer-50 and resus-
pended in 12.5 l of wash buffer-50 to make a 1:1 slurry. Aliquots of the bead
slurry (5 l), supernatant (5 l) or original translation reaction (2.5 l) were
added to Laemmli’s sample buffer (125 mM Tris-Cl, pH 6.8, 4% SDS, 0.005%
bromphenol blue, 20% glycerol, 0.72 M -mercaptoethanol), heated to 100°C
for 3 min, and electrophoresed in a 4–20% polyacrylamide/SDS gel. The gel
was fixed in 25% isopropyl alcohol, 10% acetic acid for 30 min, dried at 80°C,
and exposed to a PhosphorImager screen overnight. The experiment shown in
Figure 1. Gel filtration analysis of the size of
recombinant Tetrahymena telomerase. TERT
protein was translated in rabbit reticulocyte
lysate in the presence of telomerase RNA, and
run over a Sephacryl S-300 column in 150 mM
potassium glutamate. (A) The fractions elut-
ing from the column were assayed for in vitro
telomerase activity. Lane I, column input. LC,
32P-labeled 100-mer DNA loading control.
1, first telomerase extension product. (B) Te-
lomerase activity (from the gel in A), levels of
telomerase RNA (from a Northern blot) and
TERT protein (from an SDS-PAGE gel) of the
column fractions were quantitated and ex-
pressed relative to the fraction with the high-
est level. The elution profile of protein stan-
dards run on the same column is indicated at
the top of the graph: thyroglobulin (669 kDa),
ferritin (440 kDa), catalase (232 kDa), aldolase
(158 kDa), and albumin (67 kDa). The void
volume contains proteins of 1500 kDa.
T.M. Bryan et al.
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Figure 3 used the above-mentioned conditions; variations of this experiment
were telomerase RNA concentrations of 20 and 80 nM; blocking buffer and
wash buffer potassium glutamate concentrations of 100 and 300 mM; and
inclusion of 1 M (GGGGTT)3 DNA primer at the mixing, immunoprecipi-
tation, and wash steps.
Biotinylated RNA Pulldowns
Biotinylated versions of wild-type and mutant (AU65–66CC) Tetrahymena
telomerase RNA were constructed by splint ligation. The plasmids pTET-
telo21-159 and pTET-telo21-159(65/66) were transcribed in vitro to produce
telomerase RNAs lacking the first 20 nt. Transcription was carried out as
described previously (Bryan et al., 2000) with the exception that the extra
MgCl2 step was omitted (because these constructs do not contain hammer-
head sequences), and GMP was added to a final concentration of 10 mM. The
latter modification resulted in the presence of 10 times more GMP than GTP
in the reaction, which would result in most of the 5 ends of the transcript
having a monophosphate, enabling subsequent ligation. An RNA oligonucle-
otide representing the first 20 nt of telomerase RNA with a 5 biotin moiety
was synthesized on a model 394 DNA/RNA synthesizer (Applied Biosys-
tems, Foster City, CA) and gel purified on a 20% polyacrylamide/8M urea
gel. This oligonucleotide, the RNA transcript and a DNA oligonucleotide
complementary to the first 40 nt of telomerase RNA (the “DNA splint”) were
combined (400 pmol of each) and ethanol precipitated. The pellet was resus-
pended in 16 l of TE (10 mM Tris-Cl, pH 8.0, 1 mM EDTA), heated to 90°C
for 3 min, and cooled slowly to 30°C over 1.5 h. The reaction was incubated
on ice for 5 min before the addition of 2 l of 10 ligase buffer (500 mM
Tris-Cl, pH 8.2, 100 mM MgCl2, 100 mM DTT, 10 mM ATP, 0.5% Triton X-100)
and 2 l of T4 DNA ligase. The ligation reaction was submerged in a 37°C
water bath for 4 h. The ligated RNA product was gel purified on an 8%
polyacrylamide/8 M urea gel.
A reticulocyte lysate translation reaction was carried out (see above) by
using pET-28a-TERT as a template and no telomerase RNA. Biotinylated and
nonbiotinylated wild-type and mutant telomerase RNAs (5 pmol) was added
to 50-l aliquots of the translation reaction either singly or together, and
incubated at 30°C for 15 min. The biotinylated RNA was precipitated from the
reaction on NeutrAvidin agarose beads (Pierce Chemical, Rockford, IL) as
follows. Beads (120 l) were washed four times in 1.8 ml of wash buffer-100
(see “Immunoprecipitations” above; contains 100 mM potassium glutamate),
centrifuging at 1500 g for 2 min between washes. The beads were incubated
twice with 1.2 ml of blocking buffer (see above; contains 100 mM potassium
glutamate) for 15 min at 4°C with agitation. Reticulocyte lysate translation
reaction with RNA (40 l) was added to 40 l of blocking buffer and centri-
fuged at 16,000  g for 10 min at 4°C to remove any particulates. The
supernatant from that spin was added to 20 l of blocked beads and agitated
at 4°C for 1 h. The beads were washed four times in 260 l of wash buffer-300
(contains 300 mM potassium glutamate) and resuspended in 20 l of wash
buffer-300 to make a 1:1 slurry. Aliquots of the bead slurry (10 l), superna-
tant (20 l), or original translation reaction (10 l) were added to 90 l of ProK
buffer (10 mM Tris-Cl, pH 7.5, 7.5 mM EDTA, 0.6% SDS, 50 g/ml proteinase
K) and incubated at 45°C for 30 min then at 95°C for 5 min to release the RNA
from the NeutrAvidin beads. The reactions were phenol/chloroform ex-
tracted (pH 8.0) and ethanol precipitated before analysis by Northern blotting
(see above). A 32P-labeled 100-mer DNA oligonucleotide (5000 cpm) was
added to the reactions before phenol/chloroform extraction as a recovery
control. The probes used for Northern blotting were tb117 (5-GAAGGT-
TATATCAGCACTAG) for wild-type telomerase RNA and tb113 (5-GAAG-
GTTATGGCAGCACTAG) for mutant AU65–66CC.
Biotinylated DNA Pulldowns
The telomeric DNA oligonucleotides used were Tet3 [(GGGGTT)2] and Bio-
Tet1 [Biotin-(GGGGTT)3]. To eliminate suspected G-quartet structure, nonte-
lomeric oligonucleotides Tet13A [TT(GAGGTT)3] and Bio-Tet33A [Biotin-
TT(GAGGTT)4] were used in subsequent experiments. Reticulocyte lysate
translated telomerase (12 l) and partially purified (DEAE) Tetrahymena ex-
tract (20 l) were incubated for 5–30 min at 30°C with telomeric (1 M) or
nontelomeric (5 M) primers, 1 telomerase buffer (see above), 100 M
ddTTP, and [-32P]dGTP at 10 M and 80 Ci/mmol (recombinant telomerase)
or 1.25 M and 800 Ci/mmol (extracts) in a total volume of 80 l. Half of each
reaction was extracted once with phenol/chloroform/isoamyl alcohol 25:24:1
and once with chloroform/isoamyl alcohol 24:1, whereas the other half re-
mained on ice. An aliquot of each (1/4) was removed as the “input” and the
remainder was added to 10 l of washed and blocked NeutrAvidin beads (see
“Immunoprecipitations” for details, except that concentrations of blocking
reagents were increased to 0.75 mg/ml (lysozyme and bovine serum albumin)
and 0.15 mg/ml (glycogen and yeast RNA), a nonspecific oligonucleotide
[PBR(24): 5-AGCCACTATCGACTACGCGATCAT] was added to a concen-
tration of 5 M and salt concentrations varied from 100 to 400 mM potassium
glutamate). Pulldowns were incubated on ice for 15 min and then washed
four times in 100 l of wash buffer (see above) at 23°C. TES (50 mM Tris-Cl,
pH 8, 20 mM EDTA, 0.2% SDS) was added to input, supernatant, and beads
fractions to a final volume of 100 l, reactions were heated to 95°C for 5 min,
phenol/chloroform extracted, and ethanol precipitated. A 32P-labeled 100-
mer DNA oligonucleotide (5000 cpm) was added to the reactions before
phenol/chloroform extraction as a recovery control. For reactions with ex-
tracts, half of each reaction was electrophoresed on a 12% polyacrylamide/
urea sequencing gel and half was subjected to Northern blotting for telom-
erase RNA. For recombinant telomerase, half of each reaction was removed
before TES addition and electrophoresed on an SDS-PAGE gel, and the
remainder was electrophoresed on a 12% polyacrylamide/urea sequencing
gel.
Native gel electrophoresis of telomerase RNA dimers
Telomerase RNAs from human and Tetrahymena were in vitro transcribed
from the plasmids pTet-telo and phTRhh that had been linearized with Ear1
and Fok1, respectively (Bryan et al., 2000), and gel-purified. Dimerization
reactions were performed essentially as described previously (Ly et al., 2003).
Unlabeled RNA (6.7 pmol) was combined with 104 cpm of end-labeled RNA
in water and denatured at 95°C for 3 min. The reactions were snap-cooled on
ice, adjusted to 25 mM Tris-Cl, pH 7.0, 50 mM NaCl and either 10 or 1.25 mM
MgCl2, and then either kept on ice () or prewarmed at 37°C or 30°C () for
2 h before electrophoresis on a 5% acrylamide nondenaturing gel in 90 mM
Tris-borate, 1 mM MgCl2 at 10 W for 1 h with no cooling.
RESULTS
Recombinant Tetrahymena Telomerase Is the Size
of a Monomer
We reconstituted active Tetrahymena telomerase by transla-
tion of 35S-labeled TERT protein in rabbit reticulocyte lysate
in the presence of in vitro-transcribed Tetrahymena telomer-
ase RNA. The size of the reconstituted telomerase complex
was analyzed by gel filtration on a Sephacryl S-300 column.
The fractions were assayed for in vitro telomerase activity
(Figure 1A) and gave a pattern of extension products with a
six-nucleotide periodicity that was previously shown to rep-
resent processive elongation of the DNA primer (Bryan et al.,
2000). The same fractions were run on SDS-PAGE gels to
determine the elution profile of the 35S-labeled TERT pro-
tein, and on a Northern blot to detect the telomerase RNA
(Figure 1B).
Telomerase activity eluted reproducibly with a peak in
column fractions 31–33. Most of the TERT protein eluted in
the void volume (representing complexes of 1500 kDa),
but there was also a protein peak in fractions 31–33. Most of
the telomerase RNA also eluted in fractions 31–33. The TERT
protein in the void showed no telomerase activity, consistent
with there being only a small amount of telomerase RNA in
this fraction. The amount of TERT protein in the void rela-
tive to that in fractions 31–33 decreased as the amount of
telomerase RNA in the reaction was increased, and TERT
protein translated in the absence of telomerase RNA eluted
completely in the void volume (our unpublished data).
Thus, it seems that TERT not in a complex with telomerase
RNA exists in large aggregates, perhaps consisting of mis-
folded protein together with chaperones or other proteins.
The elution profile of telomerase was compared with that
of proteins of known molecular mass run on the same col-
umn (Figure 1B). Fractions 31–33 correspond to a molecular
mass of180–220 kDa. TERT protein (with T7 and His tags)
is 137 kDa and telomerase RNA is 52 kDa, so a complex
consisting of one TERT plus one RNA would be 189 kDa,
whereas a dimer would be 378 kDa. The elution profile of
active Tetrahymena telomerase is thus most consistent with it
being a monomeric complex of one TERT with one RNA.
The above-mentioned results were reproduced in seven
separate runs of the Sephacryl column. The reticulocyte
lysate translation reactions were untreated or treated in
several different ways to remove unincorporated [35S]methi-
onine and/or aggregated material before running of the
column. Treatments included filtration on a 0.2-m filter
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and size exclusion on either a Microcon 100 or a BioSpin P6
column. The column was also run with translation reaction
that had been concentrated fourfold on a Microcon 100
column (to a final TERT concentration of 80 nM), in case
dimerization of telomerase is concentration-dependent, with
no change in the results. Increasing the amount of telomer-
ase RNA 10-fold (to 200 nM) also did not change the appar-
ent molecular mass of the complex.
An Artificial Telomerase Dimer Elutes at Approximately
Its Expected Mass
Because the proteins used as size markers were globular
proteins rather than ribonucleoproteins, it seemed possible
that the elution profile of telomerase did not represent its
true mass. We therefore constructed a control molecule that
should mimic a Tetrahymena telomerase dimer. We made a
construct that encodes two tandem telomerase RNAs, sepa-
rated by a 12-nucleotide linker (called “double RNA”). A
mutation in the template region (C48U) was incorporated
into one of the RNAs to be able to distinguish activity arising
from either half of the molecule. Two constructs were made,
one with C48U in the most 5 RNA, and one with this
mutation in the 3 RNA. Each of these RNAs was in vitro
transcribed and included in a reticulocyte lysate translation
reaction with TERT. The C48U mutation results in just one
band in a standard telomerase activity assay, as opposed to
the processive reaction seen with wild-type RNA. Telomer-
ase assays on each of the double RNA constructs showed
that the wild-type template was active regardless of its
position in the double RNA molecule (our unpublished
data). Activity was only 4% of that obtained with wild-
type telomerase RNA, indicating that only a small propor-
tion of the double RNA molecule formed a complex with
one or more TERT molecules and/or that the conformation
of the double RNA interfered with its normal function.
The double RNA complex with the C48U mutation in the
5 half was run on a Sephacryl S-300 column. Telomerase
activity was too weak to be detected in the column fractions,
and most of the TERT protein was in the void volume
(Figure 2B). However, a Northern blot showed that the RNA
eluted with a peak in fraction 27 (Figure 2, A and B), corre-
sponding to a molecular mass of460–550 kDa. This is only
Figure 2. Gel filtration analysis of an artificial Tetrahymena telomerase dimer. TERT protein was translated in the presence of an RNA
construct consisting of two copies of telomerase RNA (double RNA) and run on a Sephacryl S-300 column. (A) Northern blot of the indicated
column fractions, with a telomerase RNA probe. IV, in vitro-transcribed double RNA. Labeled RNA size markers are shown on the left (with
size in nucleotides). (B) Quantitation of levels of RNA (from A) and levels of TERT protein in the same fractions (from an SDS-PAGE gel).
The elution pattern of size standards is shown (see Figure 1 legend for identities of standards). (C) Comparison of the elution profiles of
double RNA in the presence of TERT (from A), wild-type telomerase RNA in the presence of TERT (from Figure 1), and wild-type telomerase
RNA alone.
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slightly larger than one would expect for the size of the RNA
molecule and two TERT molecules (378 kDa). This suggests
that the telomerase ribonucleoprotein does not run at a
vastly aberrant size on this column.
As a further control for the mass of molecules in different
fractions of the column, we ran in vitro-transcribed telom-
erase RNA alone (in the absence of both TERT and reticu-
locyte lysate). This RNA peaked in fraction 35, correspond-
ing to a molecular mass of 105–125 kDa (Figure 2C). Because
telomerase RNA has a molecular mass of 52 kDa, it elutes
at a higher mass from the column than expected. However,
this result and that of the double RNA described above
suggest that telomerase RNPs elute at slightly higher masses
than expected, so it is unlikely that the apparent mass of
180–220 kDa for wild-type telomerase is an underestimate.
We also ran partially purified extract from vegetatively
growing Tetrahymena on the Sephacryl column. Telomerase
activity eluted in fraction 27, at 460–550 kDa (our unpub-
lished data). This is consistent with results others have ob-
tained (Greider and Blackburn, 1987; Wang and Blackburn,
1997) and could indicate that Tetrahymena telomerase exists
as a dimer in vivo but is equally consistent with it being a
monomer with other proteins present in the complex.
Coimmunoprecipitation of Tagged Tetrahymena
Telomerase Detects Only One TERT per Complex
Coimmunoprecipitation of differentially tagged TERT mol-
ecules from human and E. crassus has provided evidence
that these proteins form multimers (Beattie et al., 2001; Arm-
bruster et al., 2001; Moriarty et al., 2002; Wang et al., 2002).
We therefore used this technique to determine whether Tet-
rahymena TERT multimerizes. TERT proteins with two dif-
ferent N-terminal tags (FLAG or T7) were expressed sepa-
rately in reticulocyte lysates in the presence of telomerase
RNA, either with or without [35S]methionine. Puromycin
was then added to the reaction to terminate translation (and
hence prevent further incorporation of 35S). FLAG-tagged
labeled protein was mixed with T7-tagged unlabeled pro-
tein, and vice versa. Immunoprecipitation was carried out
by using immobilized FLAG or T7 antibodies, and aliquots
of the input, supernatant, and antibody beads were electro-
phoresed on SDS-PAGE gels to visualize labeled TERT pro-
tein (Figure 3).
The left panel in Figure 3 shows each of the labeled
proteins alone as a control, demonstrating that no detectable
FLAG-TERT is precipitated by T7 beads and vice versa
(lanes 6 and 9). The right panel of Figure 3 shows immuno-
precipitation of the mixed proteins. No labeled FLAG-TERT
is detectable on T7 beads and vice versa (lanes 18 and 21).
Thus, we are not able to detect multimerization of Tetrahy-
mena TERT. Each of the positive control beads was also
loaded on the gel as a 1:5 dilution to demonstrate that as
little as one-fifth the amount of labeled protein would still be
detectable (lanes 4, 12, 16 and 24). If all of the TERT protein
existed in dimeric complexes, the amount of labeled FLAG-
TERT pulled down on T7 beads would be half the intensity
of that pulled down on FLAG beads.
The conditions used to attempt to promote dimerization
in this experiment (i.e., separate translation followed by
incubation at 30°C for 15–60 min) could conceivably be
ineffective; however, we also carried out experiments in
which the two proteins were cotranslated in the same reac-
tion, followed by coimmunoprecipitation and detection on
Western blots, and no dimerization was detectable (our un-
published data).
The experiments in Figure 3 were repeated under several
different experimental conditions in an effort to encourage
dimerization. The concentration of potassium glutamate
used during immunoprecipitation and washing was varied
from 50 to 300 mM. Telomerase RNA was included at con-
centrations of 20 to 200 nM, and the immunoprecipitation
was carried out in the presence or absence of 1 M telomeric
DNA primer. The results of all of these experiments were
identical to those shown in Figure 3.
Pulldown of Biotinylated Tetrahymena Telomerase RNA
Molecules Detects Only One RNA per Complex
Results from the coimmunoprecipitation experiments de-
scribed above made it unlikely that there was more than one
TERT molecule in the active complex. However, the resolu-
tion of the gel filtration column (Figure 1) was not fine
enough to be able to rule out the existence of a complex of
one TERT molecule with two telomerase RNA molecules.
We therefore devised a strategy to detect dimerization of the
RNA.
Figure 3. No coimmunoprecipitation of two differentially tagged Tetrahymena TERT proteins. FLAG-tagged or T7-tagged TERT was
translated in rabbit reticulocyte lysate in the presence of telomerase RNA, either with or without [35S]methionine. Each translation reaction
was then assayed separately (left) or mixed in the presence of puromycin and incubated for 15 min at 30°C (right). The translation reactions
were immunoprecipitated with FLAG antibody beads or T7 antibody beads (IP). Aliquots of the reticulocyte lysate translation reaction (R),
supernatant (S), and beads (B) were loaded on an SDS-PAGE gel. A 1:5 dilution of the beads was also loaded (indicated by triangle above
lane). Protein size markers are indicated on the left.
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Telomerase RNA was biotinylated at its 5 end, mixed
with nonbiotinylated telomerase RNA, reconstituted into a
complex with reticulocyte lysate-translated TERT, and iso-
lated by affinity purification on NeutrAvidin beads. Telom-
erase activity assays confirmed that the biotinylated RNAs
supported telomerase activity (our unpublished data). The
RNA used was either wild-type or had a mutation incorpo-
rated at nontemplate positions 65 and 66 (AU to CC) to be
able to distinguish mutant from wild-type on a Northern
blot. The probes used for wild-type or mutant RNA were
completely specific (our unpublished data). Biotinylated
wild-type and mutant RNA were efficiently isolated on the
beads (Figure 4, A and B, lanes 3 and 17) with very little
background binding of nonbiotinylated RNA (lanes 7 and
21). When biotinylated mutant RNA was reconstituted with
TERT in the presence of nonbiotinylated wild-type RNA, no
wild-type RNA was detectable after affinity purification
(Figure 4A, lane 14). The converse was also true (Figure 4B,
lane 24). Again, the RNA on positive control beads was
readily detectable when loaded at a fivefold dilution (lanes
4, 11, 18, and 28). An SDS-PAGE gel of 35S-labeled TERT
protein (Figure 4C) demonstrated that the protein was not
lost during affinity purification of the RNA; it also confirmed
that affinity purification of the complex was dependent on
having biotin on one or the other of the RNAs. Thus, we
were able to detect the presence of only one telomerase RNA
molecule per telomerase complex.
Pulldown of Biotinylated DNA Primers Fails to Detect
Telomerase Dimerization in Tetrahymena Extracts
To be able to assay for dimerization in native Tetrahymena
extracts, we modified a procedure developed by Prescott
and Blackburn (1997) for yeast telomerase, based on strepta-
vidin purification of extended telomerase products. One
biotinylated (Bio-Tet1) and one nonbiotinylated (Tet3) telo-
meric primer were extended separately or together in the
presence of radiolabeled dGTP and ddTTP, and the reac-
tions were subjected to pulldown with NeutrAvidin agarose
beads. Tet3 is shorter than Bio-Tet1 so their extended prod-
ucts are distinguishable on an acrylamide gel (Figure 5A).
As long as the telomerase complex stays bound to its prod-
uct for long enough to complete the assay, the presence of a
telomerase dimer will be revealed by pulldown of the non-
biotinylated products with the biotinylated ones.
When we carried out this assay using recombinant Tetra-
hymena telomerase, efficient pulldown of the biotinylated
products was observed, there was little background binding
of the nonbiotinylated products to the beads, and TERT
protein remained bound to the beads (Figure 5, A and B). A
significant amount of nonbiotinylated Tet3 products was
recovered in the presence of Bio-Tet1 (marked with an as-
terisk in Figure 5A), which at first seemed to be evidence of
dimerization. To control for the dependence on TERT of this
effect, we carried out a similar reaction in which the primers
were extended by telomerase and then the reaction was
phenol/chloroform extracted before NeutrAvidin pulldown
(Figure 5, C and D). Importantly, the same amount of Tet3
products was pulled down with Bio-Tet1 in the presence or
absence of TERT. A similar result was obtained when the
reactions were treated with both RNase and phenol/chloro-
form before NeutrAvidin pulldown (our unpublished data).
This indicates that the observed binding is protein and RNA
independent and is most likely mediated by intermolecular
DNA interactions.
We speculated that the DNA interactions might involve
the formation of intermolecular G-quartets, which is a well-
known property of oligonucleotides containing runs of gua-
nines in the presence of monovalent cations such as K
(Hardin et al., 2000). To test this, we repeated the experiment
with nontelomeric primers consisting of repeats of the se-
quence GAGGTT, which should be much less likely to form
G-quartets. Products of the nonbiotinylated nontelomeric
primer were not recovered with the biotinylated products
either in the presence or absence of protein (Figure 6, A and
B, asterisks). Thus, we conclude that the interacting products
seen in Figure 5 are an artifact most likely due to G-quartet
formation and that no dimerization of native Tetrahymena
telomerase is discernible using this assay.
Figure 4. No pulldown of a marked telomerase RNA with biotin-
ylated telomerase RNA. Wild-type or mutant (AC65–66UU) Tetra-
hymena telomerase RNA was in vitro transcribed and incubated
with reticulocyte lysate-translated TERT. Bio-wt and Bio-mut indi-
cate RNA biotinylated at the 5 end, wild-type and mutant, respec-
tively. The translation reactions were then either assayed separately
or mixed and incubated for 15 min at 30°C, before pulldown on
NeutrAvidin beads. (A) Northern blot of reticulocyte lysate trans-
lation reaction (R), supernatant (S), and beads (B) from the indicated
reactions, using a probe specific for wild-type telomerase RNA. A
1:5 dilution of the beads was also loaded. Telomerase RNA and a
100-mer labeled DNA loading control (LC) are indicated with ar-
rows. M, labeled RNA markers, with sizes in nucleotides. (B) North-
ern blot of the indicated samples, using a probe specific for mutant
telomerase RNA. (C) The samples from A and B were run on an
SDS-PAGE gel, and the 35S-labeled TERT protein visualized with a
PhosporImager.
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The experiment in Figure 6 was carried out with extracts
from mating Tetrahymena. Identical results were obtained
with extracts from vegetatively growing Tetrahymena (our
unpublished data). We verified that the telomerase complex
was being pulled down with its reaction products by ob-
serving telomerase RNA on the beads by using a Northern
blot (Figure 6C). Because Tetrahymena telomerase does not
remain bound to its product as tightly as yeast telomerase
(Greider, 1991; Prescott and Blackburn, 1997), only a small
proportion of the telomerase RNA was recovered (5–20% in
different experiments). Thus, this assay is less sensitive than
it is with yeast telomerase; we estimate that we would be
unable to detect dimers if they that constitute 40–50% of
the active telomerase. We were unable to carry out this
experiment using reticulocyte lysate telomerase because the
amount of telomerase bound to product was even lower,
possibly due to faster dissociation of recombinant telomer-
ase from nontelomeric DNA. Attempts to verify that the
RNA observed in Figure 6C remained in a complex with
TERT were unsuccessful due to the lack of sensitivity of
available Tetrahymena TERT antibodies, but at least at the
beginning of the experiment native gel electrophoresis dem-
onstrated that all of the telomerase RNA was in a protein
complex (our unpublished data).
Free Tetrahymena Telomerase RNA Does Not Dimerize
In Vitro
It has recently been demonstrated that under certain in vitro
conditions, protein-free human telomerase RNA can form a
dimer via an intermolecular pseudoknot (Ly et al., 2003).
Because an intramolecular pseudoknot is conserved be-
tween ciliate and mammalian telomerase RNAs (Romero
and Blackburn, 1991; Chen et al., 2000), we sought to deter-
mine whether Tetrahymena telomerase RNA can dimerize
under similar conditions. When in vitro transcribed human
telomerase RNA was prewarmed to 37°C for 2 h in the
presence of 10 mM MgCl2 before electrophoresis on a non-
denaturing polyacrylamide gel, a slower migrating band
was observed (Ly et al., 2003; Figure 7). This band is depen-
dent on the prewarming treatment and has been shown to
consist of two RNA molecules (Ly et al., 2003). When Tetra-
hymena telomerase RNA was subjected to the same condi-
tions, no dimer was observed (Figure 7). A faint slower-
migrating band was neither dependent on prewarming nor
of a mobility consistent with an RNA dimer. Because recom-
binant Tetrahymena telomerase activity is maximal at 30°C
and 1.25 mM MgCl2 (Bryan, unpublished data), we also
preincubated the RNA under these conditions, but again we
did not observe a dimer (Figure 7).
DISCUSSION
The multimerization state of telomerase has implications for
the mechanism of action of the enzyme. We therefore sought
to determine whether Tetrahymena telomerase is active as a
dimer or higher-level multimer, as has been shown for yeast,
human, and E. crassus telomerase (Prescott and Blackburn,
1997; Armbruster et al., 2001; Beattie et al., 2001; Wenz et al.,
2001; Wang et al., 2002). To our surprise, recombinant Tetra-
hymena telomerase eluted from a gel filtration column at a
size consistent with it being a monomer. We were also
unable to detect any dimerization of Tetrahymena telomerase
Figure 5. With recombinant telomerase, pull-
down of a nonbiotinylated telomeric primer can
be observed, but it is independent of TERT pro-
tein. Biotinylated telomeric DNA primer (Bio-
Tet1) and nonbiotinylated primer (Tet3) were
extended separately or together by recombinant
Tetrahymena telomerase. The reactions were then
subject to pulldown with NeutrAvidin beads di-
rectly (A and B) or extracted with phenol/chlo-
roform before NeutrAvidin bead pulldown (C
and D). Input (I), supernatant (S), and beads (B)
from the pulldowns were electrophoresed on
10% denaturing polyacrylamide gels to visualize
DNA products (A and C) and SDS-PAGE gels to
visualize 35S-labeled TERT protein (B and D).
Lanes P in D are the protein samples before
phenol/chloroform extraction. LC, 100-mer la-
beled DNA loading control.
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by coprecipitation experiments, using tags on either the
TERT protein or telomerase RNA. We therefore conclude
that a majority, if not all, of the recombinant Tetrahymena
telomerase in our reconstitution system is present as a mo-
nomeric complex of one TERT molecule with one telomerase
RNA molecule, and that Tetrahymena telomerase does not
need to dimerize to be active.
One intriguing rationale for the function of a telomerase
dimer was that the extended DNA product could be passed
from one active site to the other, allowing processive elon-
gation (Wenz et al., 2001). Our reticulocyte-reconstituted
Tetrahymena telomerase is, however, moderately processive
(Bryan et al., 2000) even though it is monomeric. It remains
possible that a dimer could be required to give higher pro-
cessivity such as that observed with human telomerase or
telomerase from Tetrahymena extracts.
Several potential artifactual explanations for our results
seem unlikely. The amino-terminal tags present on the TERT
proteins in our experiments might possibly alter the confor-
mation of the protein and interfere with dimerization. How-
ever, amino-terminal tags on both copies of human TERT do
not interfere with dimerization (Wenz et al., 2001). Similarly,
it cannot be argued that our results are solely an artifact of
the reticulocyte lysate system used for reconstitution, be-
cause dimerization has been observed for human telomerase
expressed in the same way (Armbruster et al., 2001; Beattie et
al., 2001; Moriarty et al., 2002).
One explanation for the results of our coimmunoprecipi-
tation experiments (Figure 3) could be that active telomerase
is in fact a dimer, but there is such a small proportion of
telomerase in an active conformation in our reconstitution
system that the dimerization is undetectable. The ineffi-
ciency of reconstitution of human telomerase in reticulocyte
lysates has been given as an explanation for the failure to
detect physical dimerization of human TERT by Western
blotting in one study (Beattie et al., 2001). However, our gel
filtration results indicate that reconstitution of Tetrahymena
telomerase is quite efficient in this system. Approximately
30% of the TERT protein was in a complex with RNA in the
experiment shown in Figure 1B, and this increased to 60%
when the amount of telomerase RNA was increased to the
levels used in the experiment in Figure 3 (our unpublished
results). If all of the TERT in Figure 3 were dimerized, the
amount of signal in the lanes assaying dimerization (lanes 18
and 21) would be half as intense as those in the positive
control lanes 15 and 23 (because lane 15, for example, would
contain labeled FLAG-FLAG homodimers as well as labeled
FLAG-T7 heterodimers, whereas any T7-T7 homodimers in
lane 18 would be unlabeled and therefore undetectable). So
even if only 60% of TERT was in an active conformation, the
intensity of the band representing a dimer would be 30% of
that of the controls (calculated as 0.5  60%), and we know
that we can detect a band even fainter than 20% of the
controls (e.g., lane 16). Therefore, we maintain that if all or
Figure 6. No pulldown of nonbiotinylated
telomerase products with biotinylated ones
using telomerase from Tetrahymena extracts.
Biotinylated nontelomeric DNA primer (Bio-
Tet33A) and nonbiotinylated primer (Tet13A)
were extended separately or together by par-
tially-purified native Tetrahymena telomerase.
The reactions were then subject to pulldown
with NeutrAvidin beads directly (A) or ex-
tracted with phenol/chloroform before Neu-
trAvidin bead pulldown (B). Input (I), super-
natant (S), and beads (B) from the pulldowns
were electrophoresed on 10% denaturing
polyacrylamide gels to visualize DNA prod-
ucts. LC, 100-mer labeled DNA loading con-
trol. (C) Northern blot of the samples in A.
Telomerase RNA and a 100-mer labeled DNA
loading control (LC) are indicated with ar-
rows. M, labeled RNA markers, with sizes in
nucleotides. V, in vitro transcribed telomerase
RNA (0.1 fmol).
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most of the active telomerase complex existed as a dimer, we
would be able to see it in these experiments.
It remains possible that a majority of the active recombi-
nant telomerase complex is monomeric and the remainder is
dimeric, but is too small a proportion to be detected in our
assays. This scenario nevertheless indicates that Tetrahymena
telomerase does not need to form a stable dimer to be active.
We were also unable to detect dimerization of native
telomerase from mating or vegetative Tetrahymena by using
a primer pulldown assay. The sensitivity of this assay is
lower with Tetrahymena telomerase than yeast, so it remains
possible that the proportion of telomerase dimers is too low
to be detectable. However, we remain confident that we
would be able to detect if all or most telomerase existed as
dimers, and our results again demonstrate that telomerase is
active as a monomer. Furthermore, if human telomerase
dimerization is mediated by an RNA-RNA interaction as has
been suggested (Ly et al., 2003), Tetrahymena telomerase
lacks the fundamental ability to form this dimer, at least
under the conditions tested here.
Why would Tetrahymena telomerase differ from that of
other species in what might be expected to be a fundamental
property of the enzyme? One speculative explanation re-
flects a difference between telomere biology of ciliated pro-
tozoa and that of other organisms. It has been suggested that
the role of telomerase dimerization might be to allow the
coordinated extension of two telomere ends simultaneously,
e.g., sister chromatids. During macronuclear development
after mating in Tetrahymena and other ciliates, the macro-
nuclear genome undergoes fragmentation into a large num-
ber of minichromosomes, which lack centromeres (reviewed
in Prescott, 1994). A major role for telomerase in ciliates is to
add telomeres to these fragments; levels of telomerase activ-
ity are higher during macronuclear development than dur-
ing vegetative growth (Greider and Blackburn, 1985). This
telomere addition probably does not require coordinated
telomerase action on two chromosome ends, and hence cil-
iate telomerase may have had no evolutionary incentive to
exist as anything other than a monomer. The recent proposal
of telomerase dimerization in another ciliate, E. crassus
(Wang et al., 2002), suggests that there may be heterogeneity
even within the ciliates with respect to this property of
telomerase.
We have shown that most recombinant and native T.
thermophila telomerase complexes contain one molecule each
of TERT and the RNA subunit. This demonstrates that this
enzyme does not need to dimerize to be active or to accom-
plish processive extension of telomeric DNA.
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